Pam Menaker Writes ABA Litigation News Article on Fosamax Case | Clifford Law Offices PC
Clifford Law Offices Provides Free CLE Program Clifford Law Offices is hosting its annual Continuing Legal Education Program on Thursday, June 13, 2024, at 3:00 p.m. CST. Register now.
Free Consultation (312) 899-9090
Select Language

    Pam Menaker Writes ABA Litigation News Article on Fosamax Case

    Find out if you have case
    Posted on October 22, 2014 To

    Pamela Sakowicz Menaker, Communications Partner at Clifford Law Offices, recently wrote an article that was published by the American Bar Association Litigation News on a recent court case that held that a defendant cannot be held liable in a products liability multi-district action if the company is compliant with Food and Drug Administration (FDA) rules. In a failure-to-warn complaint alleging the drug company, Merck, was negligent in its labeling following an injury to a patient, a New Jersey district court held the plaintiff’s action failed because the original label was complaint with FDA standards. To read more about this interesting case, please read “No Failure-to-Warn if FDA Compliant